Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 03 1995, 746-749, Vol 39, No. 3
TW Vahlenkamp, A De Ronde, J Balzarini, L Naesens, E De Clercq, MJ van Eijk, MC Horzinek and HF Egberink
The antiviral efficacy of acyclic nucleoside phosphonates, including 9-
(2-phosphonylmethoxyethyl)adenine (PMEA) and (R)-9-(2-
phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against feline
immunodeficiency virus (FIV) infection was determined. (R)-PMPDAP showed
the highest selectivity index (> 2,000) in vitro. Treatment of
experimentally FIV-infected asymptomatic cats with PMEA or (R)-PMPDAP had
no effect on the CD4+/CD8+ ratio. However, mean plasma viral RNA
concentrations decreased significantly in the (R)-PMPDAP-treated cats. Our
data show that, in comparison to PMEA, (R)-PMPDAP is a more potent and less
toxic inhibitor of FIV replication both in vitro and in vivo.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection
Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»